2138 — EC Healthcare Income Statement
0.000.00%
Last trade - 00:00- HK$1.30bn
- HK$2.74bn
- HK$4.21bn
- 57
- 61
- 31
- 47
Annual income statement for EC Healthcare, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,949 | 2,080 | 2,920 | 3,875 | 4,211 |
| Cost of Revenue | |||||
| Gross Profit | 1,733 | 1,845 | 2,570 | 3,322 | 3,545 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,570 | 1,796 | 2,549 | 3,688 | 4,099 |
| Operating Profit | 378 | 285 | 371 | 187 | 112 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 361 | 266 | 321 | 136 | 16.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 310 | 226 | 271 | 107 | 15.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 287 | 193 | 198 | 69.7 | -18.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 287 | 193 | 198 | 69.7 | -18.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.287 | 0.11 | 0.153 | 0.027 | -0.016 |
| Dividends per Share |